SV

Street Verdict

Analyst Scorecard

A record of what Deven Choksey said publicly, with the source. Not advice.

“Bullish on Glenmark Pharmaceuticals with a target of ₹2300. The call implies a positive outlook on the stock's performance.”

Deven Choksey’s track record (trackable calls only): 47 graded calls · 95% CI 41–69%

Glenmark PharmaceuticalsBullishCalled 18 Nov 2025Graded 23 Apr 2026
Verdict:HIT

R4 TARGET_CALL: entered ₹1840.8 on 2025-11-19 (next trading session's close); target ₹2300 reached at close ₹2335 on 2026-04-23. Window 365 days — rule H3: a target call whose quote states no time frame is given 12 months, the broker convention.

How it played out

How this is worked out
Time to target
The target was reached on a close 103 trading sessions (155 calendar days) after the entry.
Worst close against it
No close was ever against the call before the target was reached. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Read the original articleSee Deven Choksey’s full track record